Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 4.99M | $65.0M | 9.22% | +1.16M | 2026-06-30 |
| BlackRock, Inc. | 4.28M | $55.0M | 7.91% | +962.0K | 2026-06-30 |
| Foresite Capital Management IV, LLC | 1.94M | $25.0M | 3.59% | -- | 2026-06-30 |
| Merck & Co., Inc. | 1.67M | $21.0M | 3.08% | -- | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 1.60M | $20.0M | 2.95% | +372.8K | 2026-06-30 |
| Foresite Capital Management V, LLC | 1.32M | $17.0M | 2.44% | -- | 2026-06-30 |
| Capital World Investors | 1.18M | $15.0M | 2.17% | +32.3K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.01M | $13.0M | 1.86% | +29.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 922.7K | $12.0M | 1.70% | -46.7K | 2026-06-30 |
| EcoR1 Capital, LLC | 732.6K | $9.0M | 1.35% | -- | 2026-06-30 |
